Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;103:2159-2164

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Swerdlow, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Swerdlow, C. D.
Related Collections
Right arrow Ablation/ICD/surgery

(Circulation. 2001;103:2159.)
© 2001 American Heart Association, Inc.


Clinical Investigation and Reports

Implantation of Cardioverter Defibrillators Without Induction of Ventricular Fibrillation

Charles D. Swerdlow, MD

From the Division of Cardiology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, Calif.

Correspondence to Charles D. Swerdlow, MD, 8635 W Third Street, Ste 1190W, Los Angeles, CA 90048. E-mail swerdlow{at}ucla.edu

Background—The upper limit of vulnerability (ULV) is the weakest shock at which ventricular fibrillation (VF) is not induced by a T-wave shock. This study tested the hypothesis that a vulnerability safety margin based on the ULV can be used as an implantable cardioverter-defibrillator implantation criterion.

Methods and Results—Implantable cardioverter-defibrillators were implanted in 80 patients if T-wave shocks did not induce VF and the baseline-rhythm R wave was >=7 mV. The T-wave shock was 10 J in the first 45 patients (group A) and 15 J in the last 35 patients (group B). After inductionless implantations, the first VF shock was programmed to the T-wave shock plus 5 J. If T-wave shocks induced VF, the ULV was measured and the first shock was programmed to the ULV+5 J. Inductionless implantations were performed in 58 patients (72%), 28 in group A (62%) and 30 in group B (86%; P=0.04). If T-wave scanning had been done at 15 J in group A patients, inductionless implantations could have been performed in 84% of them. At 3 months, VF was induced twice during electrophysiological study in 75 patients (94%). All VFs were detected in <=4.7 s and were terminated by the first shock. During follow-up, 197 of 198 appropriate first shocks for rapid ventricular tachycardia or VF (99%) were successful in patients who had inductionless implantations (95% confidence intervals, 97% to 100%).

Conclusion—Inductionless implantations can be performed in >80% of implantable cardioverter-defibrillator recipients using a vulnerability safety margin based on a T-wave scan at 15 J.


Key Words: defibrillation • defibrillators, implantable • shock




This article has been cited by other articles:


Home page
EuropaceHome page
B. Lemke, T. Lawo, M. Zarse, A. Lubinski, U. Kreutzer, J. Mueller, A. Schuchert, S. Mitzenheim, D. Danilovic, T. Deneke, et al.
Patient-tailored implantable cardioverter defibrillator testing using the upper limit of vulnerability: the TULIP protocol
Europace, August 1, 2008; 10(8): 907 - 913.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. D. Day, R. N. Doshi, P. Belott, U. Birgersdotter-Green, M. Behboodikhah, P. Ott, K. A. Glatter, S. Tobias, H. Frumin, B. K. Lee, et al.
Inductionless or Limited Shock Testing Is Possible in Most Patients With Implantable Cardioverter- Defibrillators/Cardiac Resynchronization Therapy Defibrillators: Results of the Multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations)
Circulation, May 8, 2007; 115(18): 2382 - 2389.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. D. Swerdlow
Reappraisal of implant testing of implantable cardioverter defibrillators
J. Am. Coll. Cardiol., July 7, 2004; 44(1): 92 - 94.
[Full Text] [PDF]


Home page
CirculationHome page
C. Swerdlow, K. Shivkumar, and J. Zhang
Determination of the Upper Limit of Vulnerability Using Implantable Cardioverter-Defibrillator Electrograms
Circulation, June 24, 2003; 107(24): 3028 - 3033.
[Abstract] [Full Text] [PDF]